Staphylococcus Aureus Clinical Trials 
This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.
This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.Target Attainment of Continuous Infusion Flucloxacillin and Cefazolin Coupled With TDM vs. Standard of Care Treatment in Patients With Complicated S. Aureus Infection
Condition: Complicated Staphylococcus Aureus (S. Aureus) Infections (CSAI) Interventions: Drug: FLU or CZO as continuous infusion; Drug: standard FLU or CZO intermittent bolus administration Sponsor: University Hospital, Basel, Switzerland Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 15, 2022 Category: Research Source Type: clinical trials
